Mary Shenoda
Hospitalist · Pompton Plains, NJNPI 1316435175
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 24 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 10 manufacturers reported payments, led by Biohaven Pharmaceutical Holding Company Ltd. at 38.3% of the total. Reporting peaked in 2022 at $663 and has fallen 94.2% since, to $38 in 2024.
Across 24 payments — averaging $43.75 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Biohaven Pharmaceutical Holding Company Ltd.$402
- Bayer$193
- GSK$148
- Biohaven Pharmaceuticals, Inc.$139
- Johnson & Johnson$55
- Lilly USA, LLC$43
- plus $70 from 4 others
What the payments were for
- Food & beverage$1,050100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Biohaven Pharmaceutical Holding Company Ltd. | 5 | $402 |
| Bayer | 4 | $193 |
| GSK | 3 | $148 |
| Biohaven Pharmaceuticals, Inc. | 2 | $139 |
| Johnson & Johnson | 3 | $55 |
| Lilly USA, LLC | 3 | $43 |
| Merck | 1 | $21 |
| Kyowa Kirin, Inc. | 1 | $18 |
| Neurocrine Biosciences, Inc. | 1 | $16 |
| Pfizer | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- NURTEC ODT$499
- Kerendia$125
- TRELEGY ELLIPTA$125
How this compares
$1,050 in reported general payments places this provider in the 85th percentile of 567 hospitalist providers in New Jersey.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Pantoprazole Sodium | 17 | $108 |
| Metoprolol Succinate | 12 | $96 |
| CefuroximeCefuroxime Axetil | 11 | $91 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 14 | $83 |
| Prednisone | 22 | $65 |
| Atorvastatin Calcium | 11 | $58 |
| Amlodipine Besylate | 13 | $47 |
Paid to pharmacies, not to this prescriber.
Other hospitalist in Pompton Plains
- Kunal ParmarPompton Plains$6K
- Smitha AgadiPompton Plains$2K
- Yaseen BaseerPompton Plains$1K
- Dany Abou JaoudePompton Plains$1K
- Mohammed UsmanToms River$33K
- Justin BaptistAtlantic City$23K
- Jhonsua Jimenez AriasMorristown$15K
- Ahmed HassaninMorristown$15K
- Mohamed BakrAtlantic City$8K
- Jason NehmadNeptune$7K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.